- Home
- MLYS vs IVT Comparison
MLYS vs IVT Comparison
Compare MLYS & IVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLYS | IVT |
|---|---|---|
| Founded | 2019 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.4B |
| IPO Year | 2023 | 2005 |
Fundamental Metrics
Financial Performance| Metric | MLYS | IVT |
|---|---|---|
| Price | $29.38 | $31.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $47.33 | $32.20 |
| AVG Volume (30 Days) | ★ 1.0M | 439.7K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | ★ 3.21% |
| EPS Growth | N/A | ★ 647.37 |
| EPS | N/A | ★ 1.42 |
| Revenue | N/A | ★ $299,169,000.00 |
| Revenue This Year | N/A | $7.58 |
| Revenue Next Year | N/A | $4.81 |
| P/E Ratio | ★ N/A | $21.96 |
| Revenue Growth | N/A | ★ 9.20 |
| 52 Week Low | $8.79 | $25.21 |
| 52 Week High | $47.65 | $31.91 |
Technical Indicators
Market Signals| Indicator | MLYS | IVT |
|---|---|---|
| Relative Strength Index (RSI) | 45.18 | 63.81 |
| Support Level | $26.85 | $26.84 |
| Resistance Level | $32.21 | $31.50 |
| Average True Range (ATR) | 1.46 | 0.56 |
| MACD | 0.27 | 0.01 |
| Stochastic Oscillator | 46.46 | 55.49 |
Price Performance
Historical ComparisonAbout MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.